CD14 and lung cancer: Moreover, another rational study was carried out on BALF as a prognostic agent for patients of lung cancer, and through a cytometric bead array, Hu et al. identified a higher level of interleukin (IL)-10 and IL-10+CD206+CD14+M2-like macrophages in the SCLC affected individuals as compared to NSCLC individuals.